Gardner Lewis Asset Management’s Verona Pharma VRNA Stock Holding History

Gardner Lewis Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-165,592	Closed	-$17.7M	–	102
2025 Q3	$17.7M	Buy	+165,592	New	+$17.3M	4.18%	3

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Gardner Lewis Asset Management's VRNA Position: Q4 2025 in Review

Gardner Lewis Asset Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 165,592 shares — an estimated $17.7M sold.

Gardner Lewis Asset Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $17.7M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Gardner Lewis Asset Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Gardner Lewis Asset Management sold 165,592 Verona Pharma shares in Q4 2025, an estimated $17.7M.
Gardner Lewis Asset Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Gardner Lewis Asset Management's Verona Pharma position peaked at $17.7M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.